Epidemiology of Acute Respiratory Failure in US Children: Outcomes and Resource Use.

Q1 Nursing Hospital pediatrics Pub Date : 2024-08-01 DOI:10.1542/hpeds.2023-007166
Folafoluwa O Odetola, Achamyeleh Gebremariam
{"title":"Epidemiology of Acute Respiratory Failure in US Children: Outcomes and Resource Use.","authors":"Folafoluwa O Odetola, Achamyeleh Gebremariam","doi":"10.1542/hpeds.2023-007166","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Acute respiratory failure recalcitrant to conventional management often requires specialized organ-supportive technologies to optimize outcomes. Variation in the availability of these technologies prompted testing of the hypothesis that outcomes and resource use will vary by not only patient characteristics but also hospital characteristics and receipt of organ-supportive technology.</p><p><strong>Methods: </strong>Retrospective study of children 0 to 20 years old hospitalized for acute respiratory failure using the 2019 Kids' Inpatient Database. Multivariable regression models identified factors associated with mortality, length of hospitalization, and costs.</p><p><strong>Results: </strong>Of an estimated 75 365 hospitalizations nationally, 97% were to urban teaching hospitals, 57% were of children < 6 years, and 58% were of males. Complex chronic conditions (CCC) existed in 62%, multiorgan dysfunction in 35%, and extreme illness severity in 54%. Mortality was 7%, length of stay 15 days, and hospital costs $77 168. Elevated mortality was associated with cumulative organ dysfunction (odds ratio [OR]:2.31, 95% confidence interval [CI]: 2.22-2.42), CCC (OR: 5.49, 95% CI: 4.73-6.37), transfer, higher illness severity, and cardiopulmonary resuscitation. Lower mortality was associated with extracorporeal membrane oxygenation (OR: 0.36, 95% CI: 0.28-0.47) and new tracheostomy (OR: 0.30, 95% CI: 0.25-0.35). Longer hospitalization was associated with transfer, infancy, CCC, higher illness severity, cumulative organ dysfunction, and urban hospitals. Higher costs accrued with noninfants, cumulative organ dysfunction, private insurance, and urban teaching hospitals.</p><p><strong>Conclusions: </strong>Hospitalizations for pediatric acute respiratory failure incurred substantial mortality and resource consumption. Efforts to reduce mortality and resource consumption should address interhospital transfer, access to organ-supportive technology, and drivers of higher severity-adjusted resource consumption at urban hospitals.</p>","PeriodicalId":38180,"journal":{"name":"Hospital pediatrics","volume":" ","pages":"622-631"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital pediatrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1542/hpeds.2023-007166","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Acute respiratory failure recalcitrant to conventional management often requires specialized organ-supportive technologies to optimize outcomes. Variation in the availability of these technologies prompted testing of the hypothesis that outcomes and resource use will vary by not only patient characteristics but also hospital characteristics and receipt of organ-supportive technology.

Methods: Retrospective study of children 0 to 20 years old hospitalized for acute respiratory failure using the 2019 Kids' Inpatient Database. Multivariable regression models identified factors associated with mortality, length of hospitalization, and costs.

Results: Of an estimated 75 365 hospitalizations nationally, 97% were to urban teaching hospitals, 57% were of children < 6 years, and 58% were of males. Complex chronic conditions (CCC) existed in 62%, multiorgan dysfunction in 35%, and extreme illness severity in 54%. Mortality was 7%, length of stay 15 days, and hospital costs $77 168. Elevated mortality was associated with cumulative organ dysfunction (odds ratio [OR]:2.31, 95% confidence interval [CI]: 2.22-2.42), CCC (OR: 5.49, 95% CI: 4.73-6.37), transfer, higher illness severity, and cardiopulmonary resuscitation. Lower mortality was associated with extracorporeal membrane oxygenation (OR: 0.36, 95% CI: 0.28-0.47) and new tracheostomy (OR: 0.30, 95% CI: 0.25-0.35). Longer hospitalization was associated with transfer, infancy, CCC, higher illness severity, cumulative organ dysfunction, and urban hospitals. Higher costs accrued with noninfants, cumulative organ dysfunction, private insurance, and urban teaching hospitals.

Conclusions: Hospitalizations for pediatric acute respiratory failure incurred substantial mortality and resource consumption. Efforts to reduce mortality and resource consumption should address interhospital transfer, access to organ-supportive technology, and drivers of higher severity-adjusted resource consumption at urban hospitals.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
美国儿童急性呼吸衰竭的流行病学:结果和资源使用。
目的:常规治疗无效的急性呼吸衰竭通常需要专门的器官支持技术来优化治疗效果。这些技术的可用性存在差异,这促使我们对以下假设进行测试:结果和资源使用不仅因患者特征而异,还因医院特征和接受器官支持技术的情况而异:方法:使用 2019 年儿童住院患者数据库对因急性呼吸衰竭住院的 0 至 20 岁儿童进行回顾性研究。多变量回归模型确定了与死亡率、住院时间和费用相关的因素:在全国约 75 365 例住院病例中,97% 的病例发生在城市教学医院,57% 的病例为 6 岁以下儿童,58% 的病例为男性。62%的患儿存在复杂慢性病(CCC),35%的患儿存在多器官功能障碍,54%的患儿病情极其严重。死亡率为 7%,住院时间为 15 天,住院费用为 77168 美元。死亡率升高与累积器官功能障碍(比值比 [OR]:2.31,95% 置信区间 [CI]:2.22-2.42)、CCC(比值比:5.49,95% 置信区间 [CI]:4.73-6.37)、转院、病情严重程度较高和心肺复苏有关。死亡率较低与体外膜氧合(OR:0.36,95% CI:0.28-0.47)和新气管切开术(OR:0.30,95% CI:0.25-0.35)有关。住院时间较长与转院、婴儿期、CCC、病情严重程度较高、累积性器官功能障碍和城市医院有关。非婴儿、累积性器官功能障碍、私人保险和城市教学医院的费用更高:结论:儿科急性呼吸衰竭住院治疗会导致大量死亡和资源消耗。降低死亡率和资源消耗的努力应针对医院间转运、器官支持技术的使用以及城市医院严重程度调整后资源消耗较高的驱动因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Hospital pediatrics
Hospital pediatrics Nursing-Pediatrics
CiteScore
3.70
自引率
0.00%
发文量
204
期刊最新文献
Testing and Treatment Thresholds for Pediatric Pneumonia in the Emergency Department. It's More Complicated Than Interpreter Use: Improving Care for Non-English-Speaking Families. Factors Associated With Nirsevimab Uptake in Healthy Newborns. Nirsevimab Administration During the Birth Hospitalization. Extravasation Identification and Management in Neonates and Pediatrics: A Cross Sectional Survey.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1